Science & Technology
Arcellx share +77 percent: Gilead Sciences secures new cancer therapy with acquisition
In a landmark move that has captured the attention of the biotech and pharmaceutical industries, Gilead ...
News and insights
Cancer Therapy
Science & Technology
Pan-KRAS destruction with a single PROTAC
KRAS mutations are among the most prevalent oncogenic drivers in human cancers, including lung, pancreat...